New Wolters Kluwer Report Charts Path Forward for Open Medicine

Rhea-AI Summary

Wolters Kluwer, Health has released a report, “The Path to Open Medicine: Driving Global Health Equity through Medical Research,” advocating for global collaboration among stakeholders in medical research. The report emphasizes that achieving global health equity requires collective action from funders, institutions, publishers, and researchers, noting that current structures are insufficient. It also highlights the importance of open access to scientific research, aligning with recent guidance from the U.S. Office of Science and Technology Policy to enhance sharing of vital research.

Positive

• The report emphasizes the importance of collaboration among stakeholders to achieve global health equity.
• Wolters Kluwer's leading role in medical research publishing enhances its capability to foster innovation.

Negative

• Current infrastructure and policies for open medicine are still inadequate, hindering progress towards health equity.
• There remains a significant barrier in the belief that a single category of stakeholder can achieve global health equity.

Paper outlines required action by industry stakeholders to drive global health equity

WALTHAM, Mass.--(BUSINESS WIRE)-- As an active participant in the fast-changing open medicine landscape, Wolters Kluwer, Health has published a new report titled, “The Path to Open Medicine: Driving Global Health Equity through Medical Research.” The paper defines what open medicine means today and sets forth a vision of how all stakeholders in the space, including funders, institutions, publishers, and researchers, must collaborate to deliver on the collective benefit of medical research and ultimately advance global health equity.

New Wolters Kluwer report on open medicine outlines required actions by industry stakeholders to drive global health equity (Photo: Business Wire)

The report is intended to sit within the ongoing global conversation around increased openness in scientific research, including the recent policy guidance issued by the U.S. Office of Science and Technology Policy (OSTP) in August 2022. This measure will ensure key research and data is shared freely and openly across the scientific and healthcare landscapes – contributing to the acceleration of scientific breakthroughs that can help save lives and equip stakeholders, from policymakers to care providers, with the information they need to drive more equitable healthcare.

A call for stakeholder collaboration in medical scholarly research
Wolters Kluwer’s new report asserts that while much progress has been accomplished towards the vision of open medicine, the necessary infrastructure, policies, and practices to truly achieve the mission that the scientific community set for itself more than 20 years ago are still not fully in place. It emphasizes that one of the main barriers is the notion that global health equity can be attained through the actions of a single category of stakeholder.

“Global health equity is a mission that carries the highest level of significance for the quality of life for people everywhere, and at Wolters Kluwer we embrace that mission fully. We regard open medicine as a key step to achieving that goal. Our leading role in medical research publishing enables us to contribute significantly to innovation, but delivering on the vision of open medicine will require collaboration across the landscape,” said Vikram Savkar, Senior Vice President & General Manager, Medicine Segment, Health Learning, Research & Practice at Wolters Kluwer, and member of the Board of Directors for The International Association for Scientific, Technical and Medical Publishers. “We look forward to aligning with other key stakeholders to make collective progress on a road forward.”

A roadmap to achieving open medicine
The report charts a path towards open medicine through a rapid broadening of where medical research is conducted, with a particular focus on ensuring that funding for medical research and dissemination of research results can be distributed globally. Detailed sections outline what it will take from stakeholders to make progress toward the collective aim of research that advances global health and equitable access to the best care everywhere. The forward-looking model also factors in anticipated advancements in policy, process and technology that will be needed to make open medicine possible.

“Delivering on the promise of open medicine will require bold leadership and unprecedented collaboration among stakeholders across the scholarly publishing industry,” said Angela Cochran, Vice President of Publishing at the American Society of Clinical Oncology and Associate Editor of The Scholarly Kitchen, “The time is now for us to commit to working toward the values of open medicine for the benefit of people from all parts of the globe.”

Learn More About Wolters Kluwer’s commitment to open medicine

About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer, Health provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005346/en/

Media

Josh DeStefano

Public Relations & Public Affairs Manager

Wolters Kluwer

Joshua.destefano@wolterskluwer.com

Source: Wolters Kluwer Health

FAQ

What is the report by Wolters Kluwer about open medicine titled?

The report is titled 'The Path to Open Medicine: Driving Global Health Equity through Medical Research.'

Who are the key stakeholders mentioned in the Wolters Kluwer report?

The report mentions funders, institutions, publishers, and researchers as key stakeholders.

What is the significance of the U.S. Office of Science and Technology Policy guidance mentioned in the report?

It aims to ensure that federally funded research is freely available, promoting openness in scientific research.

What challenges does the Wolters Kluwer report identify in achieving open medicine?

The report identifies inadequate infrastructure and the misconception that one category of stakeholder can achieve health equity as significant challenges.

How does Wolters Kluwer plan to contribute to advancing global health equity?

By advocating for collaboration among stakeholders and enhancing open access to medical research.